More SEC Filings
View Older Stories View Newer Stories-
Form 4 Bionano Genomics, Inc. For: Feb 02 Filed by: Holmlin R. Erik
-
Form 8-K BASSETT FURNITURE INDUST For: Feb 04
-
Form 4 DESTINATION XL GROUP, For: Feb 02 Filed by: Rubin Elaine
-
Form 4 NOVANTA INC For: Feb 02 Filed by: Glastra Matthijs
-
Form SCHEDULE 13G/A Riot Platforms, Inc. Filed by: JANE STREET GROUP, LLC
-
Form 497K Capitol Series Trust
-
Form 13F-HR SUMMIT WEALTH GROUP LLC For: Dec 31
-
Form 4 Akebia Therapeutics, For: Feb 02 Filed by: Grund Nicholas
-
Form 4 Andersen Group Inc. For: Feb 02 Filed by: Vorsatz Mark Lawrence
-
Form 4 DESTINATION XL GROUP, For: Feb 02 Filed by: Ross Ivy
-
Form 4 LENNOX INTERNATIONAL For: Feb 02 Filed by: BEDAPUDI PRAKASH
-
Form 8-K CROWN HOLDINGS, INC. For: Feb 04
-
Form 4 Hims & Hers Health, Inc. For: Feb 03 Filed by: Okupe Oluyemi
-
Form N-MFP3 Dreyfus Institutional For: Jan 30
-
Form 8-K UNIVERSAL INSURANCE HOLD For: Feb 04
-
Form 4 COMCAST CORP For: Feb 03 Filed by: NAKAHARA ASUKA
-
Form 4 Akebia Therapeutics, For: Feb 02 Filed by: Burke Steven Keith
-
Form 4/A FULLER H B CO For: Jan 26 Filed by: Martin Celine Christine
-
Form N-MFP3 Dreyfus Institutional For: Jan 30
-
Form 144 Axos Financial, Inc. Filed by: Garrabrants Gregory
-
Form 4 DESTINATION XL GROUP, For: Feb 02 Filed by: MESDAG WILLEM
-
Form 13F-HR Ameritas Advisory Servic For: Dec 31
-
Form 10-Q WinVest Acquisition Corp For: Mar 31
-
Form 8-K PTC INC. For: Feb 04
-
Form 144 ABERCROMBIE & FITCH CO Filed by: Horowitz Fran
-
Form 424B2 CITIGROUP INC
-
Form 8-K Kinsale Capital Group, For: Jan 30
-
Form 4 DESTINATION XL GROUP, For: Feb 02 Filed by: Conacher Lionel F.
-
Form 10-Q Fluence Energy, Inc. For: Dec 31
-
Form 4 Rapport Therapeutics, For: Feb 02 Filed by: Ignelzi Troy A.
-
Form 4 Century Therapeutics, For: Feb 02 Filed by: Carr Douglas
-
Form 8-K Helmerich & Payne, Inc. For: Feb 04
-
Form 4 DESTINATION XL GROUP, For: Feb 02 Filed by: Boyle Jack
-
Form 4 LENNOX INTERNATIONAL For: Feb 02 Filed by: Maskara Alok
-
Form 424B2 BofA Finance LLC
-
Form 4 Akebia Therapeutics, For: Feb 02 Filed by: Rucci Carolyn M.
-
Form 424B2 BARCLAYS BANK PLC
-
Form 4 DESTINATION XL GROUP, For: Feb 02 Filed by: Bauza Carmen
-
Form 4 Karyopharm Therapeutics For: Feb 03 Filed by: Macomber Lori
-
Form 10-Q LESAKA TECHNOLOGIES INC For: Dec 31
-
Form 6-K Banco Santander (Brasil) For: Mar 31
-
Form 4 LPL Financial Holdings For: Feb 02 Filed by: Khanna Somesh
-
Form 8-K Snap Inc For: Feb 04
-
Form 3 Sezzle Inc. For: Jan 23 Filed by: Brading Lee Dickson
-
Form 144 FIRST BANCORP /NC/ Filed by: CRAWFORD JAMES C III
-
Form 4 TEXAS CAPITAL BANCSHARES For: Feb 02 Filed by: STALLINGS ROBERT W
-
Form SCHEDULE 13G/A Cellectar Biosciences, Filed by: Hexstone Capital LLC
-
Form 4 Rapport Therapeutics, For: Feb 02 Filed by: Yeleswaram Krishnaswamy
-
Form 4 Doximity, Inc. For: Feb 02 Filed by: Wampler Kira Scherer
-
Form N-CSR Natixis Funds Trust II For: Nov 30

